{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:17:47Z","timestamp":1785403067827,"version":"3.56.0"},"reference-count":36,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006472","name":"Grigore T. Popa University of Medicine and Pharmacy Iasi","doi-asserted-by":"publisher","award":["2302\/2022"],"award-info":[{"award-number":["2302\/2022"]}],"id":[{"id":"10.13039\/501100006472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006472","name":"Grigore T. Popa University of Medicine and Pharmacy Iasi","doi-asserted-by":"publisher","award":["9990\/2022"],"award-info":[{"award-number":["9990\/2022"]}],"id":[{"id":"10.13039\/501100006472","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2302\/2022"],"award-info":[{"award-number":["2302\/2022"]}],"id":[{"id":"https:\/\/ror.org\/03hd30t45","id-type":"ROR","asserted-by":"publisher"}]},{"award":["9990\/2022"],"award-info":[{"award-number":["9990\/2022"]}],"id":[{"id":"https:\/\/ror.org\/03hd30t45","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background: Frailty has been linked with systemic inflammation in elderly oncology patients. In this paper, we report the results of an analysis evaluating the association between blood cell biomarkers of inflammation and frailty in patients with operable non-small-cell lung cancer (NSCLC). Methods: A retrospective analysis was performed on patients undergoing surgery for NSCLC between March 2022 and March 2023. Frailty was assessed using the modified Frailty Index-5 (mFI-5) and 11 (mFI-11). Inflammation was evaluated using the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune\u2013inflammation index (SII), and systemic immune\u2013inflammation response index (SIRI), all calculated from preoperative assessments. Results: In this sample of surgical NSCLC patients (n = 106), frailty prevalence was 29.2% with mFI-11 and 17% with mFI-5. The log of the neutrophil-to-lymphocyte ratio (logNLR) emerged as the most significant predictor of frailty (OR of 3.13, 95% CI: 1.12\u20139.09, p = 0.03 for mFI-11 and 3.82, 95% CI: 1.28\u201311.11, p = 0.02 for FI-5). The platelet-to-lymphocyte ratio (PLR) was predictive only in the model assessing mFI-5. Furthermore, both the NLR and PLR showed an inverse linear correlation with frailty severity, a finding that remained consistent regardless of age, gender, disease stage, nutrition status, or comorbidity burden. Conclusions: Frail patients with operable NSCLC exhibit distinct inflammatory response patterns compared with those observed in non-frail lung cancer patients. Using these biomarkers could help identify patients suitable for preoperative interventions that could improve their postoperative course. However, further studies are needed to explore these preliminary findings prospectively and to understand the causal relationship between the observed association with frailty status and severity.<\/jats:p>","DOI":"10.3390\/medsci14020170","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:57:11Z","timestamp":1774864631000},"page":"170","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Association Between Inflammatory Scores and Frailty Severity: An Exploratory Retrospective Analysis in Non-Small-Cell Lung Cancer Surgical Patients"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9736-8455","authenticated-orcid":false,"given":"Radu-Alexandru","family":"Iacobescu","sequence":"first","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5825-6189","authenticated-orcid":false,"given":"Vasile Lucian","family":"Boiculese","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-6077","authenticated-orcid":false,"given":"Gianina","family":"Dodi","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiberiu","family":"Lunguleac","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Grigorescu","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3727-231X","authenticated-orcid":false,"given":"Sabina","family":"Antoniu","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"ref_1","first-page":"409","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ageing\/afaa219","article-title":"Prevalence of frailty in 62 countries across the world: A systematic review and meta-analysis of population-level studies","volume":"50","author":"Sezgin","year":"2021","journal-title":"Age Ageing"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.chest.2022.02.027","article-title":"Frailty in Patients with Lung Cancer: A Systematic Review and Meta-Analysis","volume":"162","author":"Komici","year":"2022","journal-title":"Chest"},{"key":"ref_5","first-page":"362","article-title":"Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology","volume":"67","author":"Ethun","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12979-023-00410-3","article-title":"Inflammatory markers and physical frailty: Towards clinical application","volume":"21","author":"Pan","year":"2024","journal-title":"Immun. Ageing"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tan, Z., Xue, H., Sun, Y., Zhang, C., Song, Y., and Qi, Y. (2021). The Role of Tumor Inflammatory Microenvironment in Lung Cancer. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.688625"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"111872","DOI":"10.1016\/j.mad.2023.111872","article-title":"The influence of inflammation and frailty in the aging continuum","volume":"215","author":"Arosio","year":"2023","journal-title":"Mech. Ageing Dev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.14740\/jocmr2959w","article-title":"C-Reactive Protein and Frailty in the Elderly: A Literature Review","volume":"9","author":"Velissaris","year":"2017","journal-title":"J. Clin. Med. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/17476348.2025.2487152","article-title":"Preoperative frailty as the strongest predictor of postoperative adverse events burden in patients with operable non-small cell lung cancer: A retrospective analysis","volume":"19","author":"Iacobescu","year":"2025","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e69936","DOI":"10.2196\/69936","article-title":"Prevalence of Frailty and Its Predictors Among Patients with Cancer at the Chemotherapy Stage: Systematic Review","volume":"11","author":"Wang","year":"2025","journal-title":"JMIR Cancer"},{"key":"ref_12","first-page":"248","article-title":"Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer","volume":"26","author":"Shoji","year":"2020","journal-title":"Ann. Thorac. Cardiovasc. Surg. Off. J. Assoc. Thorac. Cardiovasc. Surg. Asia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.18632\/aging.101575","article-title":"Inflammation markers are associated with frailty in elderly patients with coronary heart disease","volume":"10","author":"Hou","year":"2018","journal-title":"Aging"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Xu, W., Liang, Y., and Lin, Z. (2021). Association Between Neutrophil-Lymphocyte Ratio and Frailty: The Chinese Longitudinal Healthy Longevity Survey. Front. Med., 8.","DOI":"10.3389\/fmed.2021.783077"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-021-00257-6","article-title":"Association of immunity markers with the risk of incident frailty: The Rugao longitudinal aging study","volume":"19","author":"Zhang","year":"2022","journal-title":"Immun. Ageing"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Han, S., Zhang, Z., Cheng, S., Han, Y., Wang, Q., Xi, Y., Li, P., Li, F., and Guo, J. (2024). Correlations between frailty index and inflammatory markers derived from blood cell count in the United States. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-20908-9"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jss.2013.01.021","article-title":"Accumulating deficits model of frailty and postoperative mortality and morbidity: Its application to a national database","volume":"183","author":"Velanovich","year":"2013","journal-title":"J. Surg. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jamcollsurg.2017.11.005","article-title":"New 5-Factor Modified Frailty Index Using American College of Surgeons NSQIP Data","volume":"226","author":"Subramaniam","year":"2018","journal-title":"J. Am. Coll. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780140810","article-title":"The log transformation is special","volume":"14","author":"Keene","year":"1995","journal-title":"Stat. Med."},{"key":"ref_20","first-page":"101","article-title":"Evaluation of frailty and neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios relationship in elderly people","volume":"84","author":"Asik","year":"2022","journal-title":"Nagoya J. Med. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/jamasurg.2025.4917","article-title":"Immune Modulation by Personalized vs Standard Prehabilitation Before Major Surgery: A Randomized Clinical Trial","volume":"161","author":"Cambriel","year":"2025","journal-title":"JAMA Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1007\/s00268-020-05658-0","article-title":"Prehabilitation in Frail Surgical Patients: A Systematic Review","volume":"44","author":"Watson","year":"2020","journal-title":"World J. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Shen, Y.J., Qian, L.Q., Ding, Z.P., Luo, Q.Q., Zhao, H., Xia, W.Y., Fu, Y.Y., Feng, W., Zhang, Q., and Yu, W. (2021). Prognostic Value of Inflammatory Biomarkers in Patients with Stage I Lung Adenocarcinoma Treated with Surgical Dissection. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.711206"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1634\/theoncologist.2016-0443","article-title":"Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy","volume":"22","author":"Scilla","year":"2017","journal-title":"Oncologist"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41598-023-50378-9","article-title":"Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer","volume":"14","author":"Ohashi","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","article-title":"Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas","volume":"69","author":"Cropet","year":"2009","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10566","DOI":"10.1038\/s41598-018-28646-w","article-title":"Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: A population-based prospective cohort study","volume":"8","author":"Fest","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2147\/COPD.S452444","article-title":"Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study","volume":"19","author":"Cai","year":"2024","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jss.2015.02.004","article-title":"Murine lung cancer induces generalized T-cell exhaustion","volume":"195","author":"Mittal","year":"2015","journal-title":"J. Surg. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1200\/JCO.2014.57.3329","article-title":"Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer","volume":"33","author":"Conlon","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_31","first-page":"1","article-title":"Immunologic changes in frail older adults","volume":"9","author":"Wang","year":"2014","journal-title":"Transl. Med. UniSa"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1007\/s13277-014-2973-y","article-title":"The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients","volume":"36","author":"Hong","year":"2015","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12957-015-0710-7","article-title":"Preoperative neutrophil\/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer","volume":"13","author":"Shimizu","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.21037\/atm.2019.09.18","article-title":"Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer","volume":"7","author":"Berardi","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tang, Y., Zhai, Y., Song, W., Zhu, T., Xu, Z., Jiang, L., Li, L., Liu, D., and Wu, Q. (2024). Association between complete blood count-derived inflammatory markers and the risk of frailty and mortality in middle-aged and older adults. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1427546"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111955","DOI":"10.1016\/j.exger.2022.111955","article-title":"Do neutrophil to lymphocyte ratio and platelet to lymphocyte ratio associate with frailty in elderly inpatient with comorbidity?","volume":"169","author":"Guan","year":"2022","journal-title":"Exp. Gerontol."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/170\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:07:10Z","timestamp":1775059630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medsci14020170"],"URL":"https:\/\/doi.org\/10.3390\/medsci14020170","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]}}}